Douglas W. Sborov
- Oncology top 5%
- Hematology top 2%
- Molecular Biology
- Immunology
- Genetics
- Co-authors
- George M. RodgersCraig C. HofmeisterNatalie S. CallanderGhulam Rehman MohyuddinFlavia PichiorriAl‐Ola AbdallahBradley M. HaverkosBrian McClune
- Topics
- Multiple Myeloma Research and Treatments (79 papers)Protein Degradation and Inhibitors (27 papers)CAR-T cell therapy research (18 papers)
- Cited by
- HematologyOncologyGenetics
- Journals
- Journal of Clinical InvestigationJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Douglas W. Sborov
104 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 77
- Oncology 602
- Hematology 591
- Molecular Biology 559
- Immunology 149
- Genetics 129
Countries citing papers authored by Douglas W. Sborov
This map shows the geographic impact of Douglas W. Sborov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas W. Sborov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas W. Sborov more than expected).
Fields of papers citing papers by Douglas W. Sborov
This network shows the impact of papers produced by Douglas W. Sborov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas W. Sborov. The network helps show where Douglas W. Sborov may publish in the future.
Co-authorship network of co-authors of Douglas W. Sborov
This figure shows the co-authorship network connecting the top 25 collaborators of Douglas W. Sborov. A scholar is included among the top collaborators of Douglas W. Sborov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas W. Sborov. Douglas W. Sborov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 10 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 2 | |
| 8 | 27 | |
| 9 | 7 | |
| 10 | 10 | |
| 11 | 6 | |
| 12 | 27 | |
| 13 | 20 | |
| 14 | 17 | |
| 15 | 10 | |
| 16 | 15 | |
| 17 | 4 | |
| 18 | 3 | |
| 19 | 31 | |
| 20 | 71 |
About Douglas W. Sborov
Douglas W. Sborov is a scholar working on Hematology, Oncology and Genetics, having authored 118 papers that have together received 1.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (79 papers), Protein Degradation and Inhibitors (27 papers) and CAR-T cell therapy research (18 papers). The work is most often cited by research in Hematology (591 citations), Oncology (602 citations) and Genetics (109 citations). Douglas W. Sborov has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include George M. Rodgers, Craig C. Hofmeister, Natalie S. Callander, Ghulam Rehman Mohyuddin, Flavia Pichiorri, Al‐Ola Abdallah, Bradley M. Haverkos, Brian McClune, Pamela Jo Harris and Ashraf Badros. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.